{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:59:21Z","timestamp":1794851961787,"version":"4.9.1"},"reference-count":143,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Recordati Rare Diseases Inc","id":[{"id":"https:\/\/ror.org\/00x68eg25","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Endogenous Cushing syndrome (CS) is a rare disorder resulting from chronic exposure to excessive concentrations of cortisol. It is likely underdiagnosed because many clinical signs and symptoms are non-specific and overlap with those of common conditions. Furthermore, biochemical testing to diagnose CS can be complex and challenging, especially in milder cases. CS is characterized by excessive daily cortisol production, but it is also associated with a disrupted circadian rhythm of cortisol secretion. Traditional cortisol monitoring techniques rely on single-time-point measurements or a cumulation of measurements, which are unable to capture the complete daily rhythm of cortisol fluctuations. Currently, the utility of assessing individual patients\u2019 cortisol circadian rhythm during diagnosis and treatment of CS is not well characterized. In this review, we will discuss how cortisol is measured in clinical practice and the potential benefit of measurement and normalization of the cortisol circadian rhythm.<\/jats:p>","DOI":"10.1210\/clinem\/dgag095","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:42:44Z","timestamp":1773333764000},"page":"1513-1527","source":"Crossref","is-referenced-by-count":7,"title":["Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-3885","authenticated-orcid":false,"given":"Oksana","family":"Hamidi","sequence":"first","affiliation":[{"name":"Division of Endocrinology, University of Texas Southwestern Medical Center , Dallas, TX 75390-8857 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-2118","authenticated-orcid":false,"given":"Matthieu","family":"St-Jean","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Sherbrooke , Sherbrooke, QC J1H 5H3 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-3025","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al , Montreal, QC H2W 1T8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"1","key":"2026051819574468700_dgag095-B1","first-page":"25","article-title":"Circadian rhythm of corticotropin-releasing activity in the hypothalamus of normal and adrenalectomized rats","volume":"7","author":"Hiroshige","year":"1971","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2026051819574468700_dgag095-B2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jcem-3-4-195","article-title":"A diurnal rhythm in the secretion of urinary ketosteroids in young men","volume":"3","author":"Pincus","year":"1943","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051819574468700_dgag095-B3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3181\/00379727-101-24955","article-title":"Nycthemeral variations in plasma free corticosteroid levels of the rat","volume":"101","author":"Guillemin","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"issue":"9","key":"2026051819574468700_dgag095-B4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1172\/JCI102798","article-title":"The normal levels of 17-hydroxycorticosteroids in the peripheral blood of man","volume":"32","author":"Bliss","year":"1953","journal-title":"J Clin Invest"},{"issue":"4514","key":"2026051819574468700_dgag095-B5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"issue":"6","key":"2026051819574468700_dgag095-B6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/endo-75-6-943","article-title":"Evidence for a precursor in vasopressin biosynthesis","volume":"75","author":"Sachs","year":"1964","journal-title":"Endocrinology"},{"issue":"5881","key":"2026051819574468700_dgag095-B7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/299355a0","article-title":"Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin","volume":"299","author":"Gillies","year":"1982","journal-title":"Nature"},{"issue":"4732","key":"2026051819574468700_dgag095-B8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.2.4732.627","article-title":"Neural control of the pituitary gland. II. The adenohypophysis, with special reference to the secretion of A.C.T.H","volume":"2","author":"Harris","year":"1951","journal-title":"Br Med J"},{"issue":"3","key":"2026051819574468700_dgag095-B9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1073\/pnas.65.3.745","article-title":"ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase","volume":"65","author":"Lefkowitz","year":"1970","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2026051819574468700_dgag095-B10","first-page":"1221","article-title":"Dynamic asymmetries in the corticosteroid feedback path and distribution of tissue receptors","volume":"216","author":"Dallman","year":"1969","journal-title":"Am J Physiol"},{"issue":"5","key":"2026051819574468700_dgag095-B11","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2026051819574468700_dgag095-B12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM198505233122102","article-title":"Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion","volume":"312","author":"Van Cauter","year":"1985","journal-title":"N Engl J Med"},{"issue":"11","key":"2026051819574468700_dgag095-B13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumors \u2013 a population-based study in Olmsted County, Minnesota","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026051819574468700_dgag095-B14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/jcem-33-1-14","article-title":"Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects","volume":"33","author":"Weitzman","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2265.1990.tb03758.x","article-title":"Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females","volume":"32","author":"Horrocks","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026051819574468700_dgag095-B16","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2008-2380","article-title":"Modified-release hydrocortisone to provide circadian cortisol profiles","volume":"94","author":"Debono","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2026051819574468700_dgag095-B17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-3782(03)00074-4","article-title":"Development of cortisol circadian rhythm in infancy","volume":"73","author":"de Weerth","year":"2003","journal-title":"Early Hum Dev"},{"issue":"11","key":"2026051819574468700_dgag095-B18","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.0808180106","article-title":"Adverse metabolic and cardiovascular consequences of circadian misalignment","volume":"106","author":"Scheer","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2026051819574468700_dgag095-B19","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.1118355109","article-title":"Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk","volume":"109","author":"Cohen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051819574468700_dgag095-B20","doi-asserted-by":"crossref","first-page":"105462","DOI":"10.1016\/j.ebiom.2024.105462","article-title":"Circadian clock disruption impairs immune oscillation in chronic endogenous hypercortisolism: a multi-level analysis from a multicentre clinical trial","volume":"110","author":"Hasenmajer","year":"2024","journal-title":"eBioMedicine"},{"issue":"1","key":"2026051819574468700_dgag095-B21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41572-024-00588-w","article-title":"Cushing syndrome","volume":"11","author":"Nieman","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2026051819574468700_dgag095-B22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s40618-022-01754-1","article-title":"Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies","volume":"45","author":"Giuffrida","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026051819574468700_dgag095-B23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jcem-48-5-760","article-title":"Circadian cortisol secretory rhythms in Cushing's disease","volume":"48","author":"Boyer","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026051819574468700_dgag095-B24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jcem-60-3-527","article-title":"The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome","volume":"60","author":"Refetoff","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2026051819574468700_dgag095-B25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJM195511032531801","article-title":"Advances in the diagnosis of altered states of adrenocortical function","volume":"253","author":"Laidlaw","year":"1955","journal-title":"N Engl J Med"},{"issue":"2","key":"2026051819574468700_dgag095-B26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jcem-20-2-253","article-title":"Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing's syndrome","volume":"20","author":"Doe","year":"1960","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026051819574468700_dgag095-B27","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026051819574468700_dgag095-B28","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","article-title":"Long-term consequences of Cushing syndrome: a systematic literature review","volume":"109","author":"Puglisi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026051819574468700_dgag095-B29","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1210\/jc.2019-00449","article-title":"Continuous free cortisol profiles-circadian rhythms in healthy men","volume":"104","author":"Bhake","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"701","key":"2026051819574468700_dgag095-B30","doi-asserted-by":"crossref","first-page":"eadg8464","DOI":"10.1126\/scitranslmed.adg8464","article-title":"High-resolution daily profiles of tissue adrenal steroids by portable automated collection","volume":"15","author":"Upton","year":"2023","journal-title":"Sci Transl Med"},{"issue":"6","key":"2026051819574468700_dgag095-B31","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1093\/ejendo\/lvaf114","article-title":"Survival probabilities in patients with ectopic Cushing's syndrome - a systematic review and a single arm meta-analysis","volume":"192","author":"Piasecka","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026051819574468700_dgag095-B32","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1210\/clinem\/dgab058","article-title":"Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality","volume":"106","author":"Schernthaner-Reiter","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ejendo\/lvad069","article-title":"Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study","volume":"189","author":"Li","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026051819574468700_dgag095-B34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ejendo\/lvae127","article-title":"Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common","volume":"191","author":"Braun","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026051819574468700_dgag095-B35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-018-1819-6","article-title":"Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"issue":"(4)","key":"2026051819574468700_dgag095-B36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/clinem\/dgaf553","article-title":"Sleep disturbances in patients with Cushing syndrome and mild autonomous cortisol secretion: a cross-sectional study","volume":"111","author":"Sharma Sharma","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026051819574468700_dgag095-B37","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026051819574468700_dgag095-B38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2026051819574468700_dgag095-B39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","article-title":"Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease","volume":"16","author":"van der Pas","year":"2013","journal-title":"Pituitary"},{"issue":"9","key":"2026051819574468700_dgag095-B40","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051819574468700_dgag095-B41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fendo.2017.00375","article-title":"Multiple salivary cortisol measurements are a useful tool to optimize metyrapone treatment in patients with Cushing's syndromes treatment: case presentations","volume":"8","author":"Yoshida","year":"2018","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026051819574468700_dgag095-B42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/EJE-19-0695","article-title":"Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease","volume":"182","author":"Newell-Price","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026051819574468700_dgag095-B43","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/clinem\/dgaf206","article-title":"Chronotherapy with once-daily osilodrostat improves cortisol rhythm, quality of life, and sleep in Cushing's syndrome","volume":"110","author":"Ferrari","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026051819574468700_dgag095-B44","first-page":"4039","article-title":"Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy","volume":"85","author":"Veldman","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026051819574468700_dgag095-B45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026051819574468700_dgag095-B46","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2026051819574468700_dgag095-B47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jcem-24-7-621","article-title":"Probability theory in the diagnosis of Cushing's syndrome","volume":"24","author":"Nugent","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051819574468700_dgag095-B48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/clinem\/dgae517","article-title":"Clinical and biochemical data for the diagnosis of endogenous hypercortisolism: the \u201ccushingomic\u201d approach","volume":"110","author":"Ceccato","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026051819574468700_dgag095-B49","doi-asserted-by":"crossref","first-page":"e3723","DOI":"10.1210\/clinem\/dgac379","article-title":"Whom should we screen for Cushing syndrome? The Endocrine Society practice guideline recommendations 2008 revisited","volume":"107","author":"Braun","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026051819574468700_dgag095-B50","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026051819574468700_dgag095-B51","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1210\/jc.2006-1791","article-title":"Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents","volume":"92","author":"Klose","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026051819574468700_dgag095-B52","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/jc.2007-0596","article-title":"Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series","volume":"92","author":"Giraldi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026051819574468700_dgag095-B53","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051819574468700_dgag095-B54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing's disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2026051819574468700_dgag095-B55","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0031-1286297","article-title":"Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism","volume":"43","author":"Deutschbein","year":"2011","journal-title":"Horm Metab Res"},{"issue":"9","key":"2026051819574468700_dgag095-B56","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/JC.2015-2078","article-title":"Cortisol measures across the weight spectrum","volume":"100","author":"Schorr","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051819574468700_dgag095-B57","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/gerona\/gly279","article-title":"Longitudinal change in cortisol levels across the adult life span","volume":"75","author":"Moffat","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2026051819574468700_dgag095-B58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem.83.2.4555","article-title":"High fluid intake increases urine free cortisol excretion in normal subjects","volume":"83","author":"Mericq","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026051819574468700_dgag095-B59","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cen.14262","article-title":"Dietary sodium intake and cortisol measurements","volume":"93","author":"Chen","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026051819574468700_dgag095-B60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.psyneuen.2014.04.018","article-title":"24 h urinary free cortisol in large-scale epidemiological studies: short-term and long-term stability and sources of variability","volume":"47","author":"Rosmalen","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"2026051819574468700_dgag095-B61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-13-0702","article-title":"Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests","volume":"170","author":"Alwani","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026051819574468700_dgag095-B62","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/BF03349791","article-title":"Morning plasma free cortisol: inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states","volume":"18","author":"Friedman","year":"1995","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026051819574468700_dgag095-B63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.11613\/BM.2021.010706","article-title":"Detection and correction of incomplete duplicate 24-hour urine collections\u2014theory and practical evidence","volume":"31","author":"Wulkan","year":"2021","journal-title":"Biochem Med"},{"issue":"8","key":"2026051819574468700_dgag095-B64","first-page":"2681","article-title":"Late-night salivary cortisol as a screening test for Cushing's syndrome","volume":"83","author":"Raff","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12995-018-0204-y","article-title":"Impact of shift work on the diurnal cortisol rhythm: a one-year longitudinal study in junior physicians","volume":"13","author":"Li","year":"2018","journal-title":"J Occup Med Toxicol"},{"issue":"2","key":"2026051819574468700_dgag095-B66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5935\/1984-0063.20220034","article-title":"Effect of night-shift work on cortisol circadian rhythm and melatonin levels","volume":"15","author":"Brum","year":"2022","journal-title":"Sleep Sci"},{"issue":"6","key":"2026051819574468700_dgag095-B67","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2265.2005.02395.x","article-title":"Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans","volume":"63","author":"Liu","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2026051819574468700_dgag095-B68","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s40618-018-0870-8","article-title":"Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population","volume":"41","author":"Aberle","year":"2018","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026051819574468700_dgag095-B69","first-page":"e220324","article-title":"Confounding effects of liquorice, hydrocortisone, and blood contamination on salivary cortisol but not cortisone","volume":"12","author":"Imamovic","year":"2022","journal-title":"Endocr Connect"},{"issue":"3","key":"2026051819574468700_dgag095-B70","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jc.2006-2155","article-title":"The relationship between smoking status and cortisol secretion","volume":"92","author":"Badrick","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026051819574468700_dgag095-B71","doi-asserted-by":"crossref","first-page":"bvaa107","DOI":"10.1210\/jendso\/bvaa107","article-title":"Prospective evaluation of late-night salivary cortisol and cortisone by EIA and LC-MS\/MS in suspected Cushing syndrome","volume":"4","author":"Kannankeril","year":"2020","journal-title":"J Endocr Soc"},{"issue":"3","key":"2026051819574468700_dgag095-B72","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/000456329703400302","article-title":"Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome\u2014recommendations for a protocol for biochemistry laboratories","volume":"34","author":"Wood","year":"1997","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"2026051819574468700_dgag095-B73","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/jc.2003-030207","article-title":"The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome","volume":"89","author":"Findling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026051819574468700_dgag095-B74","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/clinem\/dgaa105","article-title":"Accuracy of laboratory tests for the diagnosis of Cushing syndrome","volume":"105","author":"Galm","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B75","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026051819574468700_dgag095-B76","first-page":"315","article-title":"Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy","volume":"75","author":"Kyriazopoulou","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"06","key":"2026051819574468700_dgag095-B77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1210910","article-title":"The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test","volume":"94","author":"Nickelsen","year":"1989","journal-title":"Exp Clin Endocrinol"},{"issue":"5","key":"2026051819574468700_dgag095-B78","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2265.2007.02784.x","article-title":"The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol","volume":"66","author":"Qureshi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026051819574468700_dgag095-B79","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1507\/endocrj1954.35.685","article-title":"Hypercortisolism and the resistance to dexamethasone suppression during gestation","volume":"35","author":"Odagiri","year":"1988","journal-title":"Endocrinol Jpn"},{"issue":"3","key":"2026051819574468700_dgag095-B80","doi-asserted-by":"crossref","first-page":"bvae002","DOI":"10.1210\/jendso\/bvae002","article-title":"Overnight 1-mg DST serum cortisol in various stages of chronic kidney disease - normative data and underlying mechanisms","volume":"8","author":"Garg","year":"2024","journal-title":"J Endocr Soc"},{"issue":"7","key":"2026051819574468700_dgag095-B81","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/clinchem\/hvab056","article-title":"Method-specific cortisol and dexamethasone thresholds increase clinical specificity of the dexamethasone suppression test for Cushing syndrome","volume":"67","author":"Vogg","year":"2021","journal-title":"Clin Chem"},{"issue":"4","key":"2026051819574468700_dgag095-B82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.1982.tb00733.x","article-title":"Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone","volume":"16","author":"Meikle","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026051819574468700_dgag095-B83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026051819574468700_dgag095-B84","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s40618-023-02099-z","article-title":"Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis","volume":"46","author":"Mondin","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"2026051819574468700_dgag095-B85","doi-asserted-by":"crossref","first-page":"1332120","DOI":"10.3389\/fendo.2024.1332120","article-title":"Accuracy of the 10 \u03bcg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis","volume":"15","author":"Giampietro","year":"2024","journal-title":"Front Endocrinol"},{"issue":"11","key":"2026051819574468700_dgag095-B86","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/clinem\/dgac492","article-title":"Approach to the patient: diagnosis of Cushing syndrome","volume":"107","author":"Savas","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"2026051819574468700_dgag095-B87","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/a-1783-7901","article-title":"The importance of DHEA-S levels in Cushing's syndrome; is there a cut-off value in the differential diagnosis?","volume":"54","author":"Ciftci","year":"2022","journal-title":"Horm Metab Res"},{"issue":"07","key":"2026051819574468700_dgag095-B88","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/a-1719-5381","article-title":"Diurnal salivary cortisol profiles in patients with Cushing's syndrome","volume":"130","author":"Braun","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"2026051819574468700_dgag095-B89","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/biomedicines9070741","article-title":"Diagnostic accuracy of dehydroepiandrosterone sulfate and corticotropin in autonomous cortisol secretion","volume":"9","author":"Carafone","year":"2021","journal-title":"Biomedicines"},{"issue":"07","key":"2026051819574468700_dgag095-B90","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2006-924281","article-title":"An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and\/or episodic hypercortisolism","volume":"114","author":"Friedman","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"2026051819574468700_dgag095-B91","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cen.13758","article-title":"Characterization of cyclic Cushing's disease using late night salivary cortisol testing","volume":"89","author":"Jahandideh","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2026051819574468700_dgag095-B92","first-page":"487","article-title":"The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome","volume":"67","author":"Kuze","year":"2016","journal-title":"Endokrynol Pol"},{"issue":"6","key":"2026051819574468700_dgag095-B93","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-07-0424","article-title":"Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome","volume":"157","author":"Kidambi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026051819574468700_dgag095-B94","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/clinem\/dgae468","article-title":"Steroid profiling and circadian cortisol secretion in patients with mild autonomous cortisol secretion: a cross-sectional study","volume":"110","author":"Saini","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jcem-59-1-161","article-title":"Circadian rhythm of serum cortisol in Cushing's disease","volume":"59","author":"Glass","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051819574468700_dgag095-B96","doi-asserted-by":"crossref","first-page":"105410","DOI":"10.1016\/j.jsbmb.2019.105410","article-title":"Serum steroid profiling in Cushing's syndrome patients","volume":"192","author":"H\u00e1na","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2026051819574468700_dgag095-B97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"2026051819574468700_dgag095-B98","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026051819574468700_dgag095-B99","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ejendo\/lvad113","article-title":"High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment","volume":"189","author":"Dogra","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026051819574468700_dgag095-B100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"7","key":"2026051819574468700_dgag095-B101","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabets Endocrinol"},{"issue":"1","key":"2026051819574468700_dgag095-B102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/clinem\/dgz052","article-title":"Glucocorticoid receptor polymorphisms influence muscle strength in Cushing's syndrome","volume":"105","author":"M\u00fcller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026051819574468700_dgag095-B103","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/oby.2003.111","article-title":"Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant","volume":"11","author":"Lin","year":"2003","journal-title":"Obes Res"},{"issue":"3","key":"2026051819574468700_dgag095-B104","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1559-4572.2008.00008.x","article-title":"A 5-year follow-up study of 3 polymorphisms in the human glucocorticoid receptor gene in relation to obesity, hypertension, and diabetes","volume":"3","author":"Rosmond","year":"2008","journal-title":"J Cardiometab Syndr"},{"issue":"1","key":"2026051819574468700_dgag095-B105","first-page":"144","article-title":"A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo","volume":"83","author":"Huizenga","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-11-0722","article-title":"Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome","volume":"166","author":"Trementino","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026051819574468700_dgag095-B107","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.2337\/diabetes.51.10.3128","article-title":"A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels","volume":"51","author":"van Rossum","year":"2002","journal-title":"Diabetes"},{"issue":"8","key":"2026051819574468700_dgag095-B108","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1210\/jc.2003-031422","article-title":"The ER22\/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults","volume":"89","author":"van Rossum","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026051819574468700_dgag095-B109","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":"Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission","volume":"91","author":"Lindsay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B110","doi-asserted-by":"crossref","first-page":"bvae201","DOI":"10.1210\/jendso\/bvae201","article-title":"Improved clinical outcomes during long-term osilodrostat treatment of Cushing disease with normalization of late-night salivary cortisol and urinary free cortisol","volume":"9","author":"Newell-Price","year":"2025","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026051819574468700_dgag095-B111","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026051819574468700_dgag095-B112","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1210\/clinem\/dgaa774","article-title":"Diabetes, active disease, and afternoon serum cortisol levels predict Cushing's disease mortality: a cohort study","volume":"106","author":"Rold\u00e1n-Sarmiento","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026051819574468700_dgag095-B113","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis","volume":"172","author":"van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026051819574468700_dgag095-B114","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026051819574468700_dgag095-B115","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","article-title":"Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years","volume":"97","author":"Hassan-Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026051819574468700_dgag095-B116","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026051819574468700_dgag095-B117","doi-asserted-by":"crossref","first-page":"E1836","DOI":"10.1210\/jc.2012-1852","article-title":"A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair","volume":"97","author":"Manenschijn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"02","key":"2026051819574468700_dgag095-B118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0029-1220771","article-title":"Hair analysis provides a historical record of cortisol levels in Cushing's syndrome","volume":"118","author":"Thomson","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2026051819574468700_dgag095-B119","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-16-0873","article-title":"Scalp hair cortisol for diagnosis of Cushing's syndrome","volume":"176","author":"Wester","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026051819574468700_dgag095-B120","doi-asserted-by":"crossref","first-page":"445\u2013","DOI":"10.1530\/EJE-20-1127","article-title":"Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome","volume":"184","author":"Brossaud","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026051819574468700_dgag095-B121","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000498886","article-title":"Hair glucocorticoids as a biomarker for endogenous Cushing's syndrome: validation in two independent cohorts","volume":"109","author":"Savas","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"3","key":"2026051819574468700_dgag095-B122","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jc.2018-01172","article-title":"Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements","volume":"104","author":"Harrison","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026051819574468700_dgag095-B123","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.amjmed.2025.04.035","article-title":"The combination of afternoon and midnight salivary cortisol improves the diagnosis of Cushing syndrome","volume":"138","author":"Lionetto","year":"2025","journal-title":"Am J Med"},{"issue":"4","key":"2026051819574468700_dgag095-B124","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1210\/jc.2015-3694","article-title":"Salivary cortisol reflects cortisol exposure under physiological conditions and after hydrocortisone","volume":"101","author":"Debono","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026051819574468700_dgag095-B125","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1210\/clinem\/dgad347","article-title":"Postoperative serum cortisol and Cushing disease recurrence in patients with corticotroph adenomas","volume":"108","author":"Catalino","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026051819574468700_dgag095-B126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-025-04234-7","article-title":"The prevalence and predictors of Cushing disease recurrence: a 10-year experience of a pituitary tumor center of excellence","volume":"89","author":"Lamback","year":"2025","journal-title":"Endocrine"},{"issue":"10","key":"2026051819574468700_dgag095-B127","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40265-025-02223-8","article-title":"Update on medical treatment of Cushing's syndrome","volume":"85","author":"Dillon","year":"2025","journal-title":"Drugs"},{"issue":"1","key":"2026051819574468700_dgag095-B128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/jc.2006-0728","article-title":"Dopamine receptor expression and function in corticotroph ectopic tumors","volume":"92","author":"Pivonello","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026051819574468700_dgag095-B129","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026051819574468700_dgag095-B130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(19)30313-4","article-title":"Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial","volume":"7","author":"Fleseriu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2026051819574468700_dgag095-B131","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026051819574468700_dgag095-B132","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1507\/endocrj.EJ19-0617","article-title":"A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11\u03b2-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease","volume":"67","author":"Tanaka","year":"2020","journal-title":"Endocr J"},{"issue":"9","key":"2026051819574468700_dgag095-B133","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2026051819574468700_dgag095-B134","doi-asserted-by":"crossref","first-page":"E2882","DOI":"10.1210\/clinem\/dgac178","article-title":"Randomized trial of osilodrostat for the treatment of Cushing disease","volume":"107","author":"Gadelha","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026051819574468700_dgag095-B135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026051819574468700_dgag095-B136","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2026051819574468700_dgag095-B137","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026051819574468700_dgag095-B138","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cen.13803","article-title":"Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess","volume":"89","author":"Hurtado","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026051819574468700_dgag095-B139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ejendo\/lvad073","article-title":"Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study","volume":"189","author":"Zhang","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026051819574468700_dgag095-B140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026051819574468700_dgag095-B141","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/clinem\/dgae250","article-title":"European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"109","author":"Beuschlein","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026051819574468700_dgag095-B142","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ejendo\/lvaf216","article-title":"Effects of metyrapone in patients with mild hypercortisolism","volume":"193","author":"Musolino","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026051819574468700_dgag095-B143","doi-asserted-by":"crossref","first-page":"bvaa202","DOI":"10.1210\/jendso\/bvaa202","article-title":"Potential transcriptional biomarkers to guide glucocorticoid replacement in autoimmune Addison's disease","volume":"5","author":"S\u00e6vik","year":"2021","journal-title":"J Endocr Soc"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag095\/67355747\/dgag095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/6\/1513\/67355747\/dgag095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/6\/1513\/67355747\/dgag095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:58:10Z","timestamp":1779148690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/6\/1513\/8523923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":143,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,14]]},"published-print":{"date-parts":[[2026,5,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag095","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,3,14]]}}}